We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BIMI market cap is 2.79k. The company's latest EPS is USD -1.6040 and P/E is -0.19.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.54M | 158k | 12.85M | 27.08M | 11.83M |
| Operating Income | -15.79M | -1.71M | -3.81M | -34.24M | -15.34M |
| Net Income | -16.79M | -4.44M | -2M | -34.99M | -22.39M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 23.05M | 30.06M | 33.2M | 38.13M | 35.71M |
| Total Liabilities | 13.07M | 21.55M | 16.31M | 26.79M | 30.5M |
| Total Equity | 9.99M | 8.51M | 16.89M | 11.34M | 5.22M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -345k | -2.07M | -3.52M | -1.28M | -10.26M |
| Investing | N/A | 167k | -725k | -697k | -538k |
| Financing | 212k | 1.84M | 3.99M | 6.14M | 8.43M |
| Market Cap | 2.79k |
| Price to Earnings Ratio | -0.19 |
| Price to Sales Ratio | 0.37 |
| Price to Cash Ratio | 1.85 |
| Price to Book Ratio | 0.83 |
| Dividend Yield | - |
| Shares Outstanding | 13.96M |
| Average Volume (1 week) | 1.73k |
| Average Volume (1 Month) | 4.8k |
| 52 Week Change | -99.97% |
| 52 Week High | 0.70 |
| 52 Week Low | 0.0001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | BIMI International Medical Inc (CE) |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.usbimi.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
